New Cancer Drug 10 Times More Potent

Author: University of Missouri-Columbia
Published: 2012/08/29 - Updated: 2022/02/12
Contents: Summary - Main - Related Publications

Synopsis: Scientist creates new cancer drug that is 10 times more potent - Drug efficiently targets breast, lung and colon cancer; Clinical trials could start within 2 years. In the study, Lee and his research team used carboranes to build new drugs designed to shut off a cancer cell's energy production, which is vital for the cell's survival. By increasing the binding strength of a drug, a smaller dose is required, minimizing side effects and increasing the effectiveness of the therapy. With carboranes, Lee found that the drug is able to bind 10 times more powerfully.

Main Digest

Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs. In a new study, MU medicinal chemists have taken an existing drug that is being developed for use in fighting certain types of cancer, added a special structure to it, and created a more potent, efficient weapon against cancer.

"Over the past decade, we have seen an increasing interest in using carboranes in drug design," said Mark W. Lee Jr., assistant professor of chemistry in College of Arts and Science. "Carboranes are clusters of three elements - boron, carbon and hydrogen. Carboranes don't fight cancer directly, but they aid in the ability of a drug to bind more tightly to its target, creating a more potent mechanism for destroying the cancer cells."

In the study, Lee and his research team used carboranes to build new drugs designed to shut off a cancer cell's energy production, which is vital for the cell's survival. All cells produce energy through complex, multi-step processes. The key to an effective drug is targeting the process that cancer cells depend on more than healthy cells. By increasing the binding strength of a drug, a smaller dose is required, minimizing side effects and increasing the effectiveness of the therapy. With carboranes, Lee found that the drug is able to bind 10 times more powerfully.

"The reason why these drugs bind stronger to their target is because carboranes exploit a unique and very strong form of hydrogen bonding, the strongest form of interactions for drugs," Lee said.

Lee said that this discovery also will lead to further uses for the drug.

Continued below image.
Chemist with test tube
Lee and his research team used carboranes to create a new cancer drug that is 10 times more potent than current cancer-fighting drugs. Credit: Nathan Hurst/University of Missouri
Continued...

"Too often, after radiation or chemotherapy, cancer cells repair themselves and re-invade the body," Lee said. "This drug not only selectively shuts off the energy production for the cancer cells, but it also inhibits the processes that allow those cancer cells to repair themselves. When we tested our carborane-based drugs, we found that they were unimaginably potent. So far, we have tested this on breast, lung and colon cancer, all with exceptional results."

According to Lee, this is the first study to show systematically how carboranes can improve the activity of a drug. Lee believes this discovery will open additional possibilities of improving drugs that are used to treat other diseases, not just cancer.

"The end result is that these new drugs could be many thousands of times more potent than the drugs that are used in the clinics today," Lee said.

While it will be several years before the new drug would be available on the market, Lee said that clinical trials could begin within the next two years. Additionally, further testing on other types of cancer is underway.

The study was published in the Journal of Medicinal Chemistry, a publication of the American Chemical Society.

Attribution/Source(s):

This quality-reviewed publication titled "New Cancer Drug 10 Times More Potent" was chosen for publishing by Disabled World's editors due to its relevance to our readers in the disability community. While the content may have been edited for style, clarity, or brevity, it was originally authored by University of Missouri-Columbia and published 2012/08/29 (Edit Update: 2022/02/12). For further details or clarifications, you can contact University of Missouri-Columbia directly at missouri.edu. Please note that Disabled World does not provide any warranties or endorsements related to this article.

📢 Discover Related Topics


👍 Share This Information To:
𝕏.com Facebook Reddit

Page Information, Citing and Disclaimer

Disabled World is an independent disability community founded in 2004 to provide disability news and information to people with disabilities, seniors, their family and/or carers. You can connect with us on social media such as X.com and our Facebook page.

Cite This Page (APA): University of Missouri-Columbia. (2012, August 29). New Cancer Drug 10 Times More Potent. Disabled World. Retrieved April 19, 2024 from www.disabled-world.com/health/cancer/treatment/potent.php

Permalink: <a href="https://www.disabled-world.com/health/cancer/treatment/potent.php">New Cancer Drug 10 Times More Potent</a>: Scientist creates new cancer drug that is 10 times more potent - Drug efficiently targets breast, lung and colon cancer; Clinical trials could start within 2 years.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified professional medical care. Any 3rd party offering or advertising does not constitute an endorsement.